Companies / Summit Therapeutics Inc.

Summit Therapeutics Inc.

Nasdaq: SMMTCIK 1599298MIAMI, FL
Insider flow · last 90 daysNet buys $51.45M

Financials · FY2024

Revenue$0
Net income$-1.08B
Total debt—
Cash$419.37M
Diluted EPS$-1.44
Shares outstanding797.7M

Ownership

797.7M shares outstanding · as of Jul 17, 2026
75.2%Insiders
Ownership
Insiders75.17%599,708,353
Institutions15.50%123,679,778
Public float9.32%74,361,471

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 9

View all →
Insider% of sharesShares
Robert W. DugganCEOCo-Chief Executive Officer · Director · 10% owner
75.18%599,708,353
Anand BhaskarChief Accounting Officer
——
Booth Robert F.Director
——
Cesano AlessandraDirector
——
Clark Kenneth ADirector
——
Huber JeffDirector
——
Ronaghi MostafaDirector
——
Xia YuDirector
——
Zanganeh MahkamCEOCo-Chief Executive Officer · Director · 10% owner
——

Institutional holders 220

View all →
HolderValue% of shares
Baker Bros. Advisors LP$689.97M4.56%
Fmr LLC$233.68M1.67%
Vanguard Group Inc$195.49M1.40%
State Street Corporation$138.95M1.20%
BlackRock, Inc.$138.84M1.19%
Geode Capital Management, LLC$62.89M0.42%
Citadel Advisors LLC$43.30M0.31%
D. E. Shaw & Co., Inc.$42.51M0.28%
Polymer Capital Management (HK) LTD$24.86M0.18%
Pictet Asset Management Holding SA$24.38M0.17%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Jun 12, 2026Robert W. Duggan
CEO
BuyCommon Stock$49.99M+3.8M
+0.67%
573,883,879
71.94% of shares
high
Jun 4, 2026Robert W. Duggan
CEO
BuyCommon Stock$1.46M+100K
+0.39%
25,824,474
3.24% of shares
high
Jan 2, 2026Cesano Alessandra
Director
GrantStock Option (right to buy)—+3K
3,219
<0.01% of shares
low
Jan 2, 2026Cesano Alessandra
Director
GrantStock Option (right to buy)—+35K
35,000
<0.01% of shares
low
Jan 8, 2026Anand Bhaskar
Executive
GrantStock Option (right to buy)—+30K
30,000
<0.01% of shares
low
Jan 2, 2026Xia Yu
Director
GrantStock Option (right to buy)—+35K
35,000
<0.01% of shares
low
Jan 2, 2026Clark Kenneth A
Director
GrantStock Option (right to buy)—+18K
17,796
<0.01% of shares
low
Jan 2, 2026Clark Kenneth A
Director
GrantStock Option (right to buy)—+35K
35,000
<0.01% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
SMMTCommon StockEquity86627T108BBG00X3GQL76